Skip to the content

KD&A - Regulatory Consultants for Medical and IVD devices

kdent@kdas.com.au
logo mainlogo darklogo light
  • About Us
    • About Us
    • What our Clients Say
    • Frequently Asked Questions
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
    • Our Clients
  • News
  • Useful Links
Get In Touch
logo main
  • About Us
    • What our Clients Say
    • Frequently Asked Questions
    • Useful Links
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
  • Latest News
  • Contact Us

Software Tag

01
Aug
Regulatory ChangesSoftwareTGA

Navigating the Updates to TGA Guidance on Excluded Software and Essential Principle 13B

In July 2024, the Therapeutic Goods Administration (TGA) released significant updates to their guidance documents on Excluded Software and Essential Principle 13B. These updates ai

Read More
Share
01
Jul
Regulatory ChangesResearch

Updates to Medical Device Regulations

Various changes have been made to the regulation of numerous types of medical devices by the TGA, including software-based medical devices, prescription spectacle lenses, medical d

Read More
Share
03
Aug
Regulatory ChangesTGA

Extension applied for acceptance of ISO 13485 manufacturer’s evidence for Class 2 and Class 3 IVD medical devices

International Standard ISO 13485:2016 Medical devices – QMS – Requirements for regulatory purposes was issued by the International Organisation for Standardisation in 2016. The

Read More
Share
28
Jun
EUFDASoftwareTGA

Meeting Medical Software Regulatory Requirements

As of 1 July 2024, new regulatory requirements for medical devices containing medicinal substances, or materials derived from animal, microbial, or recombinant sources will take ef

Read More
Share
07
Jul
Regulatory Changes

Medical Device Software – Potential for Consistent Regulation in Asia

The Asian Harmonization Working Party (AHWP) has published a white paper on medical software for comment. The AHWP has developed the paper in conjunction with the EU and the US wit

Read More
Share
News Categories
  • EU
  • FDA
  • Regulatory Changes
  • Research
  • Software
  • Technology
  • TGA
  • Uncategorized
Latest Articles
March 20, 2025
Understanding Requirements for Medical Devices Containing Medicinal, Microbial, Recombinant, or Animal Origin Substances
February 13, 2025
TGA Recall Reforms: A Closer Look at the PRAC
December 6, 2024
KD&A Can Help You From the Start – Medical Devices Steps to Market
Tags

Australia Australian Medical Device Regulatory Framework European Union Manufacturer's Evidence Medical Device Medical Device Regulations Medicinal Substances Regulatory Changes Regulatory Compliance Regulatory Requirements Regulatory Strategy TGA

  • What We Do
  • Who We Help
  • What our Clients Say
+ 61 411 101 392
kdent@kdas.com.au

Get our latest expert updates to your inbox

KD&A provides expert regulatory consulting service to medical device and IVD companies selling on Australian and International markets.

    Contact us:
    kdent@kdas.com.au
    +61 411 101 392
    Our address:
    Level 3, Suite 301,
    27 Belgrave Street,
    Manly NSW, Australia
    Our social:
    Terms and conditions
    Privacy policy
    © 2025 KD&A Pty Ltd
    w

    Lorem ipsum dolor sit amet, consectetur adipiscing elit eiusmod tempor

    w
    leroux@qodeinteractive.com